Postma Robert W's Form 4 filing
Alaunos Therapeutics, Inc. (TCRT) · filed Jun 26, 2025
- Accession no.
- 0000950170-25-090587
- Filed
- Jun 26, 2025
- Trade date
- Apr 11-Jun 24, 2025
- Filing delay
- 76 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 2 derivative transactions. It was filed 76 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Postma Robert WCIK 0001827847 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 13, 2025 | Common Stock | AGrant or awardAcquired | +20,804 | $2.92 | +$60,747.68 | 29,083 | Direct | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 11, 2025 | Common Stock | PPurchaseAcquired | +181,159 | $2.76 | +$1,380 | 500 | Indirect | |
| Jun 24, 2025 | Common Stock | PPurchaseAcquired | +133,630.29 | $4.49 | +$2,694 | 600 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.